Abbott LaboratoriesABT -0.04%80 Quick Ratio is 1.01 as of Mar. 2026, which is 18% below its 10-year median of 1.23. GuruFocus rates ABT with a GF Score™ of 80/100 and a GF Value™ of $129.49 (Significantly Undervalued). Among 854 Medical Devices & Instruments companies, Abbott Laboratories ranks worse than 77.4% on this metric.
Abbott Laboratories has a quick ratio of 1.01. It generally indicates good short-term financial strength.
The historical rank and industry rank for Abbott Laboratories's Quick Ratio or its related term are showing as below:
ABT'
s Quick Ratio Range Over the Past 10 Years
Min: 1.01 Med: 1.23 Max: 3.65
Current: 1.01
During the past 13 years, Abbott Laboratories's highest Quick Ratio was 3.65. The lowest was 1.01. And the median was 1.23.
ABT's Quick Ratio is ranked worse than 77.4% of 854
companies
in the Medical Devices & Instruments industry
Industry Median: 1.865
vs ABT: 1.01
Abbott Laboratories (NYSE:ABT) Quick Ratio Explanation
The quick ratio is more conservative than the Current Ratio because it excludes inventories from current assets. The ratio derives its name presumably from the fact that assets such as cash and marketable securities are quick sources of cash. Inventories generally take time to be converted into cash, and if they have to be sold quickly, the company may have to accept a lower price than book value of these inventories. As a result, they are justifiably excluded from assets that are ready sources of immediate cash.
In general, low or decreasing quick ratios generally suggest that a company is over-leveraged, struggling to maintain or grow sales, paying bills too quickly or collecting receivables too slowly. On the other hand, a high or increasing quick ratio generally indicates that a company is experiencing solid top-line growth, quickly converting receivables into cash, and easily able to cover its financial obligations. Such companies often have faster inventory turnover and cash conversion cycles.
The higher the quick ratio, the better the company's liquidity position.
Abbott Laboratories Quick Ratio Related Terms
Abbott Laboratories Quick Ratio Historical Data
* Premium members only.
The historical data trend for Abbott Laboratories's Quick Ratio can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Devices subindustry, Abbott Laboratories's Quick Ratio, along with its competitors' market caps and Quick Ratio data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Abbott Laboratories Quick Ratio vs Medical Devices & Instruments Industry
For the Medical Devices & Instruments industry and Healthcare sector, Abbott Laboratories's Quick Ratio distribution charts can be found below:
* The bar in red indicates where Abbott Laboratories's Quick Ratio falls into.
The quick ratio measures a company's ability to meet its short-term obligations with its most liquid assets. For this reason, the ratio excludes inventories from current assets.
Abbott Laboratories's Quick Ratio for the fiscal year that ended in Dec. 2025 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Abbott Laboratories (ABT) has a Quick Ratio of 1.01 as of Mar. 2026. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Abbott Laboratories and its competitors. This is 18% below median its historical median of 1.23. Over the past decade, Abbott Laboratories' Quick Ratio has ranged from 1.01 to 3.65. According to the industry distribution chart, Abbott Laboratories ranks #661 out of 854 companies in the Medical Devices & Instruments industry, placing it in the top 77.4%.
Is Abbott Laboratories' Quick Ratio too high?
Abbott Laboratories' current Quick Ratio of 1.01 is 18% below median its 10-year median of 1.23. Over the past 10 years, this metric has ranged from a low of 1.01 to a high of 3.65. The Medical Devices & Instruments industry median Quick Ratio is 1.87. Abbott Laboratories' value of 1.01 is 45.8% below this industry median. Based on the distribution chart, Abbott Laboratories ranks #661 out of 854 companies in the Medical Devices & Instruments industry, which is in the bottom quartile relative to peers. Overall, Abbott Laboratories has a GF Score™ of 80/100 and is considered Significantly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Abbott Laboratories' Quick Ratio compare to SYK and MDT?
According to the Medical Devices & Instruments industry distribution chart, Abbott Laboratories ranks #661 out of 854 companies for Quick Ratio. This places Abbott Laboratories in the lower half of its industry. The industry median Quick Ratio is 1.87. Abbott Laboratories' value of 1.01 is 45.8% below this benchmark. Historically, Abbott Laboratories' own Quick Ratio has ranged from 1.01 to 3.65 over the past decade. While the company's 10-year median is 1.23 vs. the industry median of 1.87, Abbott Laboratories has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Quick Ratio for a Medical Devices & Instruments company?
The median Quick Ratio among Medical Devices & Instruments companies is 1.87, based on 854 companies in the industry. Companies in the top quartile (top 25%) have a Quick Ratio significantly above this median, while those in the bottom quartile fall well below. However, Quick Ratio should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Abbott Laboratories's current Quick Ratio of 1.01 is 45.8% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Quick Ratio mean?
A high Quick Ratio can signal that a stock is expensive relative to its fundamentals. Quick ratio is the ratio of current assets less inventory to current liabilities. View historical data on Abbott Laboratories and its competitors. For the Medical Devices & Instruments industry, the median Quick Ratio is 1.87 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Abbott Laboratories's current Quick Ratio is 1.01, which is 18% below median its own 10-year median of 1.23. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Abbott Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Abbott Laboratories (ABT) is currently considered Significantly Undervalued. The stock's GF Value™ is $129.49, compared to a current price of $90.49 — trading 30.1% below its estimated fair value. The current Quick Ratio is 1.01, which is 18% below median its 10-year median of 1.23 and 45.8% below the Medical Devices & Instruments industry median of 1.87. Abbott Laboratories' overall GF Score™ is 80/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Quick Ratio calculated?
Quick Ratio is calculated from a company's financial statements. For Abbott Laboratories (ABT), the current Quick Ratio is 1.01 as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Abbott Laboratories (ABT) Overvalued in 2026?
Based on GuruFocus' analysis, Abbott Laboratories stock appears to be undervalued.
The current stock price of $90.49 is trading 30.1% below its estimated GF Value™ of $129.49.
GuruFocus considers Abbott Laboratories to be Significantly Undervalued.
Key valuation signals for ABT:
Quick Ratio: 1.01 (18% below median its 10-year median of 1.23)
GF Value™: $129.49 vs. price of $90.49 (30.1% below fair value)
Industry Position: 45.8% below the Medical Devices & Instruments median (#661 of 854)
No single metric tells the full story. See the ABT stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Abbott manufactures and markets cardiovascular and diabetes devices, adult and pediatric nutritional products, diagnostic equipment and testing kits, and branded generic drugs. Products include pacemakers, implantable cardioverter defibrillators, neuromodulation devices, coronary stents, catheters, infant formula, nutritional liquids for adults, continuous glucose monitors, and immunoassays and point-of-care diagnostic equipment. Abbott derives roughly 60% of sales outside the United States.
80GF Score
Get the complete analysis for ABT
Quick Ratio is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
ABT has been successfully added to your 
